Feature | October 09, 2013

Researchers find improved overall survival for LS-SCLC patients

October 9, 2013 — Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC). Approximately 39 percent of patients with SCLC are diagnosed with limited-stage disease. These patients are often treated with chemotherapy and definitive radiation therapy. Staging information is essential because of the high propensity for metastatic disease in SCLC, and the identification of metastases can spare patients from the toxicity associated with thoracic radiotherapy. Furthermore, in those patients who do receive radiotherapy, knowing the exact extent of disease may permit more accurate treatment volume delineation.

Until 2011, the National Comprehensive Cancer Network (NCCN) recommended a bone scan as part of the initial evaluation of all newly diagnosed SCLC patients. However, in 2012, the NCCN began recommending positron emission tomography computed tomography (PET-CT) in lieu of bone scan. Researchers from the University of Pennsylvania wanted to know the clinical impact of using PET instead.

A study published in the July issue of the Journal of Thoracic Oncology (JTO), concluded that PET-CT improves staging accuracy and intrathoracic disease identification, which translates into an improvement in clinical outcome in these patients.

"Pretreatment PET staging of LS-SCLC was associated with improved survival," reported the authors. "PET-staged patients had an improved three-year overall survival from diagnosis (47 percent versus 19 percent) compared with those with LS-SCLC who were not staged with PET." The lead author of this work was Eric Xanthopoulos, M.D. International Association fort the Study of Lung Cancer (IASLC) co-authors included Corey Langer, Charles Simone and Ramesh Rengan.

For more information: www.iaslc.org

Related Content

News | PET Imaging

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2021
arrow
News | PET Imaging

October 18, 2021 — PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the ...

Time October 18, 2021
arrow
Feature | PET Imaging | By Todd Sasser, Ph.D.

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to ...

Time September 14, 2021
arrow
News | Nuclear Imaging

August 27, 2021 — The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) issued two cooperative ...

Time August 27, 2021
arrow
News | PET-CT

August 4, 2021 — PET/CT systems are expected to continue to incorporate the highest clinical performance of PET as well ...

Time August 04, 2021
arrow
News | Molecular Imaging

August 2, 2021 — The global molecular imaging market was evaluated at $4.199 billion for the year 2019 growing at a CAGR ...

Time August 02, 2021
arrow
News | RSNA

July 21, 2021 — Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly ...

Time July 21, 2021
arrow
News | PET-CT

July 13, 2021 — In a recent blog, the American Society of Nuclear Cardiology (ASNC) reported that Humana, one of the ...

Time July 13, 2021
arrow
News | PET Imaging

July 10, 2021 — A performance evaluation of the uEXPLORER total-body PET/CT scanner showed that it exhibits ultra-high ...

Time July 10, 2021
arrow
News | Radiation Therapy

June 29, 2021 — UPMC Hillman Cancer Center will be the first cancer center in the eastern United States, and one of just ...

Time June 29, 2021
arrow
Subscribe Now